The Problem: It is alleged the drug causes an eye disorder called maculopathy and other disorders of the retina that may lead to blindness.
The Response: Cases are being accepted from patients who have taken Elmiron for a long period of time and have developed serious vision problems during or shortly after use.
What Can We Do to Help: Our experienced attorneys can review your medical records and advise you if filing a case is in your best interest.
Janssen Pharmaceuticals, the drug company responsible for Elmiron, does not list the risk of developing serious vision issues under Elmiron’s possible side effects and warnings.
Despite IC affecting millions each year, it is also the sole drug that has been FDA approved to treat pain associated with the condition. Both experts and physicians presented their research to the American Academy of Opthalmology, in which they stated that their findings added “strong support to the growing body of evidence that links long-term PPS use to the potential development of a toxic maculopathy.” The studies conducted have shown that Elmiron affects the macula, which is found in the backside of the eye. The macula is the back of the retina, which is responsible for sensing light and sending such signals to the brain, which allows for vision. Maculopathy, or the degradation of the macula, can very likely lead to blindness.
Elmiron has been linked to a specific type of maculopathy known as pigmentary maculopathy. If the issue is caught and use of the drug is suspended, damage could cease. But, studies have yet to be done on long-term effects on sight.
Some symptoms associated with Elmiron-linked macular damage include:
· Notable areas of vision loss in field of vision
· Difficulty acclimating to changes in light
· Difficulty reading
· Difficulty with close-up vision
· Dimming of vision
Current and former users of Elmiron that have developed serious vision issues after taking Elmiron for at least two years, especially if they were taking Elmiron within the last two years, may be entitled to compensation from Janssen Pharmaceuticals. If you or someone you know have used the drug to treat symptoms of IC without knowing the risks to vision health, please contact our firm at 1-800-Gallon1 (1-800-425-5661) or fill out a free case evaluation form. We want to help you get the compensation you deserve.